L-Norepinephrine前駆物質L-threo-3,4-Dihydroxy-phenylserineによるHarmaline振戦の抑制

概要

論文の詳細を見る
Effect of 3, 4-dihydroxyphenylserine (DOPS), a norepinephrine precursor, on harmaline tremor was investigated in mice to elucidate the role of norepinephrine in the genesis of tremor. 1) Spontaneous motor activity was inhibited by L-threo-DOPS (200 mg/kg i.p.). 2) Tremor induced by harmaline (5 and 7 mg/kg i.p.) was enhanced by α-methyl-p-tyrosine (200 mg/kg i.p.). 3) The development and duration of tremor induced by harmaline (10 mg/kg i.p.) were inhibited significantly in a dose dependent manner by L-threo-DOPS (50, 70, 100, 150 and 200 mg/kg i.p.), but neither by D-threo-DOPS (200 mg/kg i.p.) nor DL-erythroDOPS (200 mg/kg i.p.). 4) L-threo-DOPS (200 mg/kg i.p.) had no effect on the development of tremor induced by tremorine (5 and 10 mg/kg i.p.), while lacrimation and diarrhea caused by tremorine was markedly inhibited. 5) Administration of harmaline (10 mg/kg i.p.) produced an increase in brain 5-hydroxytryptamine content but not in that of norepinephrine. Administration of L-threo-DOPS (100 mg/kg i.p.) increased the norepinephrine content but not the 5-hydroxytryptamine content in the brain. Inhibition of harmaline tremor induced by L-threo-DOPS is attributed to the L-norepinephrine converted from L-threoDOPS and the involvement of a noradrenergic mechanism in harmaline tremor has to be considered.
社団法人日本薬理学会の論文